Skip to main content
 

NPS MedicineWise Logo
 
  • Home
  • COVID-19
    COVID-19

    Our COVID-19 information hub has important information for everyone, including resources about vaccines and treatments.

    View more NPS MedicineWise podcasts
    Featured topics
    • 09 May 2022 COVID-19 vaccine booster doses
    • 23 Feb 2022 FAQs: use of COVID-19 oral antiviral agents in residential aged care
    • 14 Feb 2022 COVID-19 vaccination side effects: how to manage and when to report them
    • 26 Oct 2021 Vaccines and COVID-19
    Featured article
    Antiviral treatments for COVID-19 Antiviral treatments for COVID-19

    Find out more about the antiviral medicines helping to treat COVID-19.

    Medicine Finder

    Find information on medicines by active ingredient or brand name

    Keep a medicines list

    The more medicines you take, the more difficult it can be to remember important information about them.

    Find out how
  • Health professionals
    Health professionals
    Featured topics
    • Mental health and young people: opportunities to empower and engage
    • Benzodiazepine dependence: reduce the risk
    • Anticholinergic burden
    • Pain management hub
    • Biosimilar medicines
    View all topics NPS MedicineWise podcasts
    Professional development
    • Professional education
    • GP
    • Pharmacists
    • Nurses and midwives
    • Aboriginal and Torres Strait Islander health professionals
    • Students
    NPS MedicineWise Publications
    • Australian Prescriber

      An independent peer-reviewed journal providing critical commentary on drugs and therapeutics.

    • RADAR

      Timely, independent, evidence-based information on new drugs and medical tests, and changes to the PBS and MBS.

    Medicine Finder

    Find information on medicines by active ingredient or brand name

    Receive Email Updates

    Latest news, evidence and CPD opportunities

  • Consumers
    Consumers
    Featured topics
    • Mental health and young people: finding the path that works for you
    • Reducing your risk of benzodiazepine dependence
    • Falls, confusion... is it my medicine?
    • Pain management hub for consumers
    View all topics NPS MedicineWise podcasts
    Talk to a professional
    • Medicines Line (1300 MEDICINE) (1300 633 424)

      Information for consumers on prescription, over-the-counter and complementary medicines.

    • Adverse Medicine Events Line (1300 134 237)

      Provides consumers with a way to report and discuss adverse experiences with medicines

    MedicineWise App
    MedicineWise App

    Keep track of medicines and access important health info any time and anywhere, especially in emergencies.

    Medicine Finder

    Find information on medicines by active ingredient or brand name

    Receive Email Updates

    Latest news, evidence and CPD opportunities

  • Publications
    Publications
    Australian Prescriber

    Independent peer-reviewed journal providing critical commentary on drugs and therapeutics for health professionals

    Current issue All issues AP podcasts
    Latest Articles
    • Oral antivirals for mild–moderate COVID‑19: a panacea or a logistical and clinical conundrum?
    • Medicines for long-term obesity management
    • The assessment of severe cutaneous adverse drug reactions
    RADAR

    Provides health professionals with timely, independent and evidence-based information

    All articles
    Latest Articles
    • PBS listing for hydroxychloroquine updated (2022)
    • Nirmatrelvir and ritonavir (Paxlovid) for mild-to-moderate COVID-19
    • Buprenorphine modified-release injections (Bivudal weekly and monthly) for opiate dependence

    Medicine Finder

    Find information on medicines by active ingredient or brand name

    Receive Email Updates

    Latest news, evidence and CPD opportunities

  • Programs
    Programs

    Our new and ongoing programs for healthcare professionals

    View all programs
    Programs
    • bDMARDs
    • Immunoglobulins
    • MedicineInsight
    • Choosing WiselyOpens a new window
    • Good Medicine Better Health
    • Quality Improvement Hub
    bDMARDs
    • Making safe and wise decisions for biological disease-modifying antirheumatic drugs (bDMARDs) and other specialised medicines.

    Immunoglobulins
    • Value in Prescribing — Immunoglobulin products.

      Immunoglobulin (Ig) products provide critical therapy for people with immunodeficiencies and immune-type neurological conditions.

    MedicineInsight
    • Improving clinical practice and health outcomes for Australia.

    Choosing Wisely
    • Provides health professionals with timely, independent and evidence-based information

    Opens a new window
    Good Medicine Better Health
    • Ongoing education for Aboriginal and Torres Strait Islander health workers and practitioners on quality use of medicines and medical tests

    Quality Improvement Hub
    • Practical information, tools and resources for health professionals and staff to help improve the quality of health care and safety for patients

    Medicine Finder

    Find information on medicines by active ingredient or brand name

    Receive Email Updates

    Latest news, evidence and CPD opportunities

  • Resources
    Resources

    Relevant, timely and evidence-based information for Australian health professionals and consumers.

    See all resources NPS MedicineWise podcasts
    Featured resources
    • Factsheet: Paxlovid for COVID-19 12 May 2022
    • 27 April 2022
    • 27 April 2022
    Featured topic
    Thyroid disease: challenges in primary care Thyroid disease: challenges in primary care

    Medicine Finder

    Find information on medicines by active ingredient or brand name

    Receive Email Updates

    Latest news, evidence and CPD opportunities

  • Partner with us
    Partner with us

    20 years of helping Australians make better decisions about medicines, medical tests and other health technologies

    Partner with us
    • QUM Grant
    • Our services
    • Health insights
    • Clinical improvement
    • Knowledge transfer
    Partnership news
    • A new Working Together agreement between CHF and NPS MedicineWise
    • PHN Immunisation Support Program
    • [email protected] palliative care resources

    Medicine Finder

    Find information on medicines by active ingredient or brand name

    Receive Email Updates

    Latest news, evidence and CPD opportunities

  • Log In
  • Register
Search
Search
 

POPULAR

  • medication safety
  • Aspirin
  • pain
  • Paracetamol
  • diabetes
  • metformin
  • Warfarin
  • Antibiotic
  • Medicines Australia
  • drug information
NPS MedicineWise Logo
  • Learning & CPD
  • About us
  • Contact us
  • Register
Log in

Log in

All fields are required

  • Don’t have an account?
  • Forgot password?
  • Home
  • RADAR
  • A
  • A

RADAR

RADAR
RADAR provides health professionals with timely, independent, evidence-based information on new drugs and medical tests and changes to listings on the Pharmaceutical Benefits Scheme and Medicare Benefits Schedule.
All articles

Subscribe to NPS MedicineWise

Register to subscribe to email updates and hear about new medicines, topics and activities.

Register now
Latest full reviews

Molnupiravir (Lagevrio) for mild-to-moderate COVID-19

Molnupiravir (Lagevrio) for mild-to-moderate COVID-19
  • 7 March 2022
  • 10 minutes

Patients at high risk of severe disease are eligible for treatment (Updated 2 May 2022)

  • Find out more

Dapagliflozin (Forxiga) for heart failure with reduced ejection fraction (LVEF ≤ 40%)

Dapagliflozin (Forxiga) for heart failure with reduced ejection fraction (LVEF ≤ 40%)

Dapagliflozin (Forxiga) for heart failure with reduced ejection fraction (LVEF ≤ 40%)

  • 27 December 2021

Palliative care: New, amended and deleted PBS items

Palliative care: New, amended and deleted PBS items

Palliative care: New, amended and deleted PBS items

  • 15 June 2021
  • 8 minutes

Opioids: New and amended PBS listings

Opioids: New and amended PBS listings

Opioids: New and amended PBS listings

  • 18 June 2020
  • 15 min read

Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia

Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia

Risperidone: Revised PBS restrictions for behavioural and psychological symptoms of dementia

  • 19 March 2020
  • 13 min read

Naloxone nasal spray (Nyxoid) for opioid overdose

Naloxone nasal spray (Nyxoid) for opioid overdose

Naloxone nasal spray (Nyxoid) for opioid overdose

  • 15 January 2020

Guanfacine (Intuniv) for attention deficit hyperactivity disorder

Guanfacine (Intuniv) for attention deficit hyperactivity disorder

Guanfacine (Intuniv) for attention deficit hyperactivity disorder

  • 18 October 2019
  • 10 min read
Wrap up
February 2022 New listings
  • 7 February 2022
Tocilizumab (actemra) shortages: further temporary listings
  • 3 December 2021
November 2021 new listing wrap-up
  • 9 November 2021
Listings: Palliative care PBS changes
  • 15 June 2021
  • 10 minutes
Latest in brief
PBS listing for hydroxychloroquine updated (2022)
  • 4 May 2022
Nirmatrelvir and ritonavir (Paxlovid) for mild-to-moderate COVID-19
  • 2 May 2022
Buprenorphine modified-release injections (Bivudal weekly and monthly) for opiate dependence
  • 1 May 2022
Empagliflozin (Jardiance) for heart failure with reduced ejection fraction (LVEF ≤ 40%)
  • 14 April 2022

Subscribe to NPS MedicineWise

Register to subscribe to email updates and hear about new medicines, topics and activities.

Register now

Date reviewed: 02 May 2022

Reasonable care is taken to provide accurate information at the time of creation. This information is not intended as a substitute for medical advice and should not be exclusively relied on to manage or diagnose a medical condition. NPS MedicineWise disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer. This website uses cookies. Read our privacy policy.

Footer

  • NPS MedicineWise Logo
  • This website is certified by Health On the Net Foundation. Opens a new window
  • Go to facebook page Opens in new window
  • Opens in new window
  • Go to linkedin page Opens in new window
  • Go to youtube page Opens in new window
  • About us
  • QUM Grant
  • Our services
  • Contact us
  • Media
  • News
  • Careers
  • Order
  • Translated info
  • Accessibility
  • Copyright
  • Terms of use
  • Whistleblower policy
  • Privacy
  • Sitemap

©2022 NPS MedicineWise.

Any queries concerning reproduction and rights should be sent to [email protected].

We acknowledge the provision of funding from the Australian Government Department of Health to develop and maintain this website.

PO Box 1147 Strawberry Hills NSW 2012

Level 7, 418A Elizabeth St, Surry Hills NSW 2010

ABN: 61 082 034 393

This website is certified by Health On the Net Foundation. Opens a new window

Our other initiatives:

  • Choosing Wisely Australia - An initiative of NPS MedicineWise Opens a new window
  • PHN (Primary Health Networks) Immunisation Support Program Opens a new window

Feedback

We are always looking for ways to improve our website


Provide feedback

Consumers: Talk to a professional (Monday – Friday, 9 am – 5 pm AET)

Medicines Line

Get medicines information:

1300 MEDICINE (1300 633 424) 1300 MEDICINE (1300 633 424) Calls triaged by healthdirect Australia

Adverse Medicine Events Line

Report a problem with medicines, medical devices or vaccines:

1300 134 237 1300 134 237 Online via the Therapeutic Goods Administration
How likely is it that you would recommend our site to a friend?

Please help us to improve our services by answering the following question

How likely is it that you would recommend our site to a friend?

0 = Not likely at all

10 = Extremely likely